1. Market Research
  2. > GinkgoPharma Co. Ltd. - Product Pipeline Review - 2013

GinkgoPharma Co. Ltd. - Product Pipeline Review - 2013

  • December 2013
  • -
  • Global Markets Direct
  • -
  • 21 pages

GinkgoPharma Co. Ltd. - Product Pipeline Review - 2013

Summary

Global Market Direct’s pharmaceuticals report, “GinkgoPharma Co. Ltd. - Product Pipeline Review - 2013” provides data on the GinkgoPharma Co. Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, GinkgoPharma Co. Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from GinkgoPharma Co. Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- GinkgoPharma Co. Ltd. - Brief GinkgoPharma Co. Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of GinkgoPharma Co. Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of GinkgoPharma Co. Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the GinkgoPharma Co. Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate GinkgoPharma Co. Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of GinkgoPharma Co. Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the GinkgoPharma Co. Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with GinkgoPharma Co. Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of GinkgoPharma Co. Ltd. and identify potential opportunities in those areas.

Table Of Contents

GinkgoPharma Co. Ltd. - Product Pipeline Review - 2013
Table of Contents

Table of Contents 2
List of Tables 3
List of Figures 3
GinkgoPharma Co. Ltd. Snapshot 4
GinkgoPharma Co. Ltd. Overview 4
Key Information 4
Key Facts 4
GinkgoPharma Co. Ltd. - Research and Development Overview 5
Key Therapeutic Areas 5
GinkgoPharma Co. Ltd. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
GinkgoPharma Co. Ltd. - Pipeline Products Glance 9
GinkgoPharma Co. Ltd. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Discovery Products/Combination Treatment Modalities 10
GinkgoPharma Co. Ltd. - Drug Profiles 11
Drug For HCV-1 11
Product Description 11
Mechanism of Action 11
RandD Progress 11
Drug For Autoimmune Disorder 12
Product Description 12
Mechanism of Action 12
RandD Progress 12
Drug For Diabetes 13
Product Description 13
Mechanism of Action 13
RandD Progress 13
Drug For HCV-2 14
Product Description 14
Mechanism of Action 14
RandD Progress 14
GinkgoPharma Co. Ltd. - Pipeline Analysis 15
GinkgoPharma Co. Ltd. - Pipeline Products by Therapeutic Class 15
GinkgoPharma Co. Ltd. - Pipeline Products by Target 16
GinkgoPharma Co. Ltd. - Pipeline Products by Molecule Type 17
GinkgoPharma Co. Ltd. - Pipeline Products by Mechanism of Action 18
GinkgoPharma Co. Ltd. - Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
Coverage 20
Secondary Research 20
Primary Research 20
Expert Panel Validation 20
Contact Us 21
Disclaimer 21



List of Tables

GinkgoPharma Co. Ltd., Key Information 4
GinkgoPharma Co. Ltd., Key Facts 4
GinkgoPharma Co. Ltd. - Pipeline by Indication, 2013 6
GinkgoPharma Co. Ltd. - Pipeline by Stage of Development, 2013 7
GinkgoPharma Co. Ltd. - Monotherapy Products in Pipeline, 2013 8
GinkgoPharma Co. Ltd. - Preclinical, 2013 9
GinkgoPharma Co. Ltd. - Discovery, 2013 10
GinkgoPharma Co. Ltd. - Pipeline by Therapeutic Class, 2013 15
GinkgoPharma Co. Ltd. - Pipeline by Target, 2013 16
GinkgoPharma Co. Ltd. - Pipeline by Molecule Type, 2013 17
GinkgoPharma Co. Ltd. - Pipeline Products by Mechanism of Action, 2013 18



List of Figures

GinkgoPharma Co. Ltd. - Pipeline by Top 10 Indication, 2013 6
GinkgoPharma Co. Ltd. - Pipeline by Stage of Development, 2013 7
GinkgoPharma Co. Ltd. - Monotherapy Products in Pipeline, 2013 8
GinkgoPharma Co. Ltd. - Pipeline by Top 10 Therapeutic Class, 2013 15



Companies Mentioned

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.